Effect of laparoscopic sleeve gastrectomy on metabolic syndrome in adolescent obesity
- PDF / 702,004 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 72 Downloads / 171 Views
ORIGINAL ARTICLE
Effect of laparoscopic sleeve gastrectomy on metabolic syndrome in adolescent obesity Mohamed El Ghazeery1 · Mohamed Elsawaf1 · Mohamed Ashour1 · Mohamed Metwaly1 · Mohamed Hashish1 Received: 12 May 2020 / Revised: 3 July 2020 / Accepted: 26 July 2020 © Springer Nature Singapore Pte Ltd 2020
Abstract Background Metabolic syndrome (MeS) is a group of physiological, biochemical, clinical, and metabolic factors which increase the incidence of atherosclerosis, type 2 diabetes mellitus, and early mortality. Overall prevalence of MeS is around 3.3%, 11.9% in overweight, 29.2% in obese, and less than 1% in non-obese children. Nearly, 90% of obese children and adolescents have at least one parameter of MeS. Objective Clinical and metabolic evaluation of obese adolescents before and after laparoscopic sleeve gastrectomy (LSG). Subjects and methods Prospective study included analysis of data from 35 adolescents (12–19 years) with body mass index (BMI) above 99th percentile for age and sex. All of them had metabolic syndrome and were submitted to LSG between 2015 and 2017. Anthropometric measurements, clinical and laboratory assessment were performed, preoperatively, 6, 12, and 24 months postoperatively. Results Mean age was 16.43 years and mean preoperative weight and BMI were 132.68 kg and 48.90, respectively. Mean excess weight loss (EWL) was 54.11 kg after 12 months’ and 51.19 kg after 24-months post-LSG, corresponding to 74 and 73 EWL%, respectively, as well as mean BMI loss (BML) of 19.89 and 18.7 kg/m2. LSG improved fatty infiltration of liver in 93% of cases and other comorbidities in 100% of patients. Conclusions Laparoscopic sleeve gastrectomy (LSG) proved as a safe and effective procedure for adolescent obesity and its related metabolic morbidities. Keywords Laparoscopy · Adolescent obesity · Sleeve gastrectomy · Metabolic syndrome
Introduction Obesity is a chronic progressive epidemic responsible for 2.8 million deaths per year. The number of obese children increased worldwide, with an estimated rise to 60 million obese children in 2020 [1]. Risk of adult obesity is 77% for obese versus 7% for non-obese children, and it has been illustrated that 7.3% of boys and 5.5% of girls in the United States are extremely obese (BMI ≥ 1.2 above the 95th percentile) [2]. The number of overweight boys more than doubled between 1989 and 2009, ascending from 15 to 34.8%. Among girls, this variation was even greater: 2.4 in 1989 to 11.8 in 2009 [3].
* Mohamed El Ghazeery [email protected] 1
Pediatric Surgery Unit, Faculty of Medicine, Tanta University, Tanta, Egypt
Metabolic syndrome (MeS) is a group of physiological, biochemical, clinical, and metabolic factors that directly increase the prevalence of atherosclerosis, type 2 diabetes mellitus (T2DM), and all-lead to early mortality. Its overall prevalence is around 3.3%, 11.9% in overweight, 29.2% in obese, and less than 1% in non-obese children. Approximately, 90% of obese children and adolescents have at least one parameter of th
Data Loading...
